| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.289 | 7.068 | 7.849 | 21.132 | 14.985 | 19.410 | 16.591 |
| Total Income - EUR | - | - | - | 4.289 | 7.068 | 7.849 | 21.132 | 16.316 | 19.411 | 16.591 |
| Total Expenses - EUR | - | - | - | 2.025 | 1.903 | 2.015 | 3.656 | 6.945 | 3.622 | 5.780 |
| Gross Profit/Loss - EUR | - | - | - | 2.264 | 5.164 | 5.834 | 17.476 | 9.371 | 15.789 | 10.811 |
| Net Profit/Loss - EUR | - | - | - | 2.135 | 4.952 | 5.606 | 16.842 | 8.947 | 13.400 | 8.936 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dermoscop Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 2.237 | 5.254 | 5.802 | 17.382 | 9.093 | 13.904 | 9.133 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 4.846 | 9.829 | 7.155 |
| Cash | - | - | - | 2.237 | 5.254 | 5.802 | 17.382 | 4.247 | 4.075 | 1.978 |
| Shareholders Funds | - | - | - | 2.178 | 5.191 | 5.737 | 17.196 | 9.001 | 13.499 | 9.052 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 59 | 62 | 64 | 185 | 92 | 405 | 231 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermoscop Med S.r.l.